MedTrace Logo

Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis

NCT00970749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2017-04-07

No results posted yet for this study

Summary

This is an exploratory study in which the investigators will develop a way to identify the cell responses most strongly associated with protection against chlamydia infection. This study is not driven by a hypothesis.

Conditions

  • Chlamydia

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Thomas L Cherpes, MD · University of Pittsburgh

Eligibility

Min Age
15 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00970749 on ClinicalTrials.gov